Insights

Innovative Disease Focus Zevra Therapeutics specializes in developing therapies for rare and underserved diseases such as Niemann-Pick Disease Type C and vEDS, which indicates a strong market niche with high unmet needs and limited competition, presenting significant opportunities for targeted outreach and partnership development.

Recent Clinical Advancements The company's recent positive clinical data presentations at prestigious industry conferences showcase its scientific credibility and commitment to advancing innovative therapeutics, making it appealing for collaborations, research partnerships, or funding opportunities with stakeholders focused on cutting-edge treatments.

Strategic Industry Engagement Active participation in influential industry events like WORLDSymposium, Guggenheim Healthcare Conference, and Canaccord Genuity Growth Conference highlights Zevra's visibility and commitment to thought leadership, presenting opportunities to connect with key opinion leaders and potential collaborators in biotech and healthcare sectors.

Strong Financial Position With substantial funding of approximately $60 million and annual revenues in the range of $25 million to $50 million, Zevra is well-capitalized, enabling potential partners or investors to explore collaborative ventures, joint research initiatives, or supply chain integrations.

Growth and Development Pipeline Zevra’s ongoing development of therapies targeting rare conditions like vEDS and Niemann-Pick Disease positions it as a growth-oriented firm with expanding product pipelines, ideal for pharmaceutical partners, distributors, or clinical service providers seeking innovation-driven collaborations.

Similar companies to Zevra Therapeutics

Zevra Therapeutics Tech Stack

Zevra Therapeutics uses 8 technology products and services including CIM Technologies, NetSuite, BugHerd, and more. Explore Zevra Therapeutics's tech stack below.

  • CIM Technologies
    Cad & Graphics
  • NetSuite
    E-commerce
  • BugHerd
    Issue Trackers
  • Glassdoor
    Online Review Management
  • HSTS
    Security
  • Google Tag Manager
    Tag Management
  • Adobe Creative Suite
    Visualisation Software
  • Google Analytics
    Web Analytics

Media & News

Zevra Therapeutics's Email Address Formats

Zevra Therapeutics uses at least 2 format(s):
Zevra Therapeutics Email FormatsExamplePercentage
FLast@kempharm.comJDoe@kempharm.com
99%
FirLast@kempharm.comJohDoe@kempharm.com
1%
FLast@zevra.comJDoe@zevra.com
100%

Frequently Asked Questions

Where is Zevra Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Zevra Therapeutics's main headquarters is located at 1180 Celebration Boulevard Celebration, Florida 34747 United States. The company has employees across 3 continents, including North AmericaEuropeSouth America.

What is Zevra Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Zevra Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Zevra Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Zevra Therapeutics's official website is zevra.com and has social profiles on LinkedInCrunchbase.

What is Zevra Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Zevra Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Zevra Therapeutics have currently?

Minus sign iconPlus sign icon
As of March 2026, Zevra Therapeutics has approximately 79 employees across 3 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: N. M.Chief Executive Officer: T. W.Chief Medical Officer: A. Q.. Explore Zevra Therapeutics's employee directory with LeadIQ.

What industry does Zevra Therapeutics belong to?

Minus sign iconPlus sign icon
Zevra Therapeutics operates in the Biotechnology Research industry.

What technology does Zevra Therapeutics use?

Minus sign iconPlus sign icon
Zevra Therapeutics's tech stack includes CIM TechnologiesNetSuiteBugHerdGlassdoorHSTSGoogle Tag ManagerAdobe Creative SuiteGoogle Analytics.

What is Zevra Therapeutics's email format?

Minus sign iconPlus sign icon
Zevra Therapeutics's email format typically follows the pattern of FLast@kempharm.com. Find more Zevra Therapeutics email formats with LeadIQ.

How much funding has Zevra Therapeutics raised to date?

Minus sign iconPlus sign icon
As of March 2026, Zevra Therapeutics has raised $60M in funding. The last funding round occurred on Aug 08, 2024 for $60M.

When was Zevra Therapeutics founded?

Minus sign iconPlus sign icon
Zevra Therapeutics was founded in 2006.

Zevra Therapeutics

Biotechnology ResearchFlorida, United States51-200 Employees

We are a purpose-driven, commercial-stage company with a late-stage pipeline committed to redefining what is possible in bringing life-changing therapies to people living with rare diseases. We involve key thought leaders, physicians, patients, care partners, and advocacy groups in all of our clinical and regulatory development strategies.

With a keen understanding that drug development often requires creative solutions, we have the insight and expertise to forge new pathways to success that others have missed. By following the data without bias, our transparent narratives and common-sense perspective have successfully overcome complex development challenges to make much-needed therapies available to patients.

Nimble and dauntless, we push boundaries beyond what is thought to be possible and advance new therapies that have the potential to bring meaningful improvement to patients’ lives.

Section iconCompany Overview

Headquarters
1180 Celebration Boulevard Celebration, Florida 34747 United States
Phone number
Website
zevra.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2006
Employees
51-200

Section iconFunding & Financials

  • $60M

    Zevra Therapeutics has raised a total of $60M of funding over 9 rounds. Their latest funding round was raised on Aug 08, 2024 in the amount of $60M.

  • $25M$50M

    Zevra Therapeutics's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $60M

    Zevra Therapeutics has raised a total of $60M of funding over 9 rounds. Their latest funding round was raised on Aug 08, 2024 in the amount of $60M.

  • $25M$50M

    Zevra Therapeutics's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.